Amgen Inc Stock Analysis
AMGN Stock | USD 333.83 2.82 0.85% |
Amgen Inc is overvalued with Real Value of 307.76 and Target Price of 258.8. The main objective of Amgen stock analysis is to determine its intrinsic value, which is an estimate of what Amgen Inc is worth, separate from its market price. There are two main types of Amgen's stock analysis: fundamental analysis and technical analysis.
The Amgen stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Amgen is usually not traded on Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday. Amgen Stock trading window is adjusted to America/New York timezone.
Amgen |
Amgen Stock Analysis Notes
About 81.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 2.42. Amgen Inc recorded earning per share (EPS) of 5.81. The entity last dividend was issued on the 16th of August 2024. The firm had 2:1 split on the 22nd of November 1999. Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California. Amgen operates under Drug ManufacturersGeneral classification in the United States and is traded on NASDAQ Exchange. It employs 24200 people. For more info on Amgen Inc please contact Robert Bradway at 805 447 1000 or go to https://www.amgen.com.Amgen Quarterly Total Revenue |
|
Amgen Inc Investment Alerts
Amgen Inc has a poor financial position based on the latest SEC disclosures | |
Over 81.0% of the company shares are held by institutions such as insurance companies | |
Latest headline from finance.yahoo.com: AMGEN TO PRESENT AT THE MORGAN STANLEY 22ND ANNUAL GLOBAL HEALTHCARE CONFERENCE |
Amgen Inc Upcoming and Recent Events
Earnings reports are used by Amgen to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
6th of February 2024 Upcoming Quarterly Report | View | |
25th of April 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
6th of February 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Amgen Largest EPS Surprises
Earnings surprises can significantly impact Amgen's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
1998-07-22 | 1998-06-30 | 0.18 | 0.21 | 0.03 | 16 | ||
1999-10-20 | 1999-09-30 | 0.24 | 0.28 | 0.04 | 16 | ||
2006-07-20 | 2006-06-30 | 0.94 | 1.05 | 0.11 | 11 |
Amgen Environmental, Social, and Governance (ESG) Scores
Amgen's ESG score is a quantitative measure that evaluates Amgen's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Amgen's operations that may have significant financial implications and affect Amgen's stock price as well as guide investors towards more socially responsible investments.
Amgen Thematic Classifications
In addition to having Amgen stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
![]() | Health ManagementHealthcare providers, hospitals | |
![]() | DrugsDrug manufacturing and delivery | |
![]() | Giant ImpactPublic companies with mega capitalization | |
![]() | Macroaxis IndexMacroaxis power theme of selected equities with solid fundamentals | |
![]() | Cash CowsCompanies that have the ability to maintain consistent cash flow over time | |
![]() | Baby Boomer ProspectsMega stocks, funds and ETFs that tend to appeal to people considering retirement from the work force | |
![]() | Robots And DronesCross-sector firms and funds that develop or invest in technology that can replicate repetitive human actions |
Amgen Stock Institutional Investors
Shares | Royal Bank Of Canada | 2024-03-31 | 5.5 M | Bank Of New York Mellon Corp | 2024-06-30 | 5.4 M | Goldman Sachs Group Inc | 2024-06-30 | 5.2 M | Legal & General Group Plc | 2024-06-30 | 4.8 M | Hhg Plc | 2024-06-30 | 4.6 M | T. Rowe Price Associates, Inc. | 2024-06-30 | 4.5 M | Barclays Plc | 2024-03-31 | 4.3 M | Fmr Inc | 2024-03-31 | 4 M | Capital Research Global Investors | 2024-06-30 | 4 M | Vanguard Group Inc | 2024-06-30 | 51.9 M | Blackrock Inc | 2024-06-30 | 46 M |
Amgen Market Capitalization
The company currently falls under 'Mega-Cap' category with a current market capitalization of 179.38 B.Amgen Profitablity
The company has Profit Margin (PM) of 0.1 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.23 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.23.Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.15 | 0.12 | |
Return On Capital Employed | 0.10 | 0.10 | |
Return On Assets | 0.07 | 0.12 | |
Return On Equity | 1.08 | 1.13 |
Management Efficiency
Amgen Inc has return on total asset (ROA) of 0.0448 % which means that it generated a profit of $0.0448 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.4927 %, meaning that it created $0.4927 on every $100 dollars invested by stockholders. Amgen's management efficiency ratios could be used to measure how well Amgen manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Amgen's Return On Assets are very stable compared to the past year. As of the 31st of August 2024, Return On Equity is likely to grow to 1.13, while Return On Tangible Assets are likely to drop 0.12. At this time, Amgen's Return On Assets are very stable compared to the past year. As of the 31st of August 2024, Asset Turnover is likely to grow to 0.51, while Other Current Assets are likely to drop about 266.9 M.Last Reported | Projected for Next Year | ||
Book Value Per Share | 11.65 | 10.26 | |
Tangible Book Value Per Share | (84.18) | (79.97) | |
Enterprise Value Over EBITDA | 14.04 | 11.29 | |
Price Book Value Ratio | 24.73 | 25.96 | |
Enterprise Value Multiple | 14.04 | 11.29 | |
Price Fair Value | 24.73 | 25.96 | |
Enterprise Value | 51.4 B | 53.9 B |
The analysis of Amgen's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Amgen's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Amgen Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Dividend Yield 0.027 | Operating Margin 0.2291 | Profit Margin 0.1012 | Forward Dividend Yield 0.027 | Beta 0.58 |
Technical Drivers
As of the 31st of August, Amgen shows the risk adjusted performance of 0.124, and Mean Deviation of 0.8915. Amgen Inc technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Amgen Inc Price Movement Analysis
The output start index for this execution was twenty-nine with a total number of output elements of thirty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Amgen middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Amgen Inc. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Amgen Inc Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Amgen insiders, such as employees or executives, is commonly permitted as long as it does not rely on Amgen's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Amgen insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Amgen Outstanding Bonds
Amgen issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Amgen Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Amgen bonds can be classified according to their maturity, which is the date when Amgen Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
AMGEN INC 515 Corp BondUS031162BK53 | View | |
AMGEN INC 3125 Corp BondUS031162BY57 | View | |
AMGEN INC 44 Corp BondUS031162BZ23 | View | |
AMGEN INC 4663 Corp BondUS031162CF59 | View | |
AMGEN INC 4563 Corp BondUS031162CD02 | View | |
AMGEN INC 26 Corp BondUS031162CJ71 | View | |
AMGEN INC 6375 Corp BondUS031162AW01 | View | |
AMGEN INC 64 Corp BondUS031162BA71 | View |
Amgen Predictive Daily Indicators
Amgen intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Amgen stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Amgen Corporate Filings
13A | 23rd of August 2024 An amended filing to the original Schedule 13G | ViewVerify |
F4 | 13th of August 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
10Q | 7th of August 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
8K | 6th of August 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 31st of July 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
21st of June 2024 Other Reports | ViewVerify | |
12th of June 2024 Other Reports | ViewVerify | |
F3 | 4th of June 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
Amgen Forecast Models
Amgen's time-series forecasting models are one of many Amgen's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Amgen's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Amgen Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Amgen prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Amgen shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Amgen. By using and applying Amgen Stock analysis, traders can create a robust methodology for identifying Amgen entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | 0.28 | 0.25 | |
Operating Profit Margin | 0.28 | 0.26 | |
Net Profit Margin | 0.24 | 0.18 | |
Gross Profit Margin | 0.70 | 0.65 |
Current Amgen Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Amgen analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Amgen analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
258.8 | Buy | 29 | Odds |
Most Amgen analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Amgen stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Amgen Inc, talking to its executives and customers, or listening to Amgen conference calls.
Amgen Stock Analysis Indicators
Amgen Inc stock analysis indicators help investors evaluate how Amgen stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Amgen shares will generate the highest return on investment. By understating and applying Amgen stock analysis, traders can identify Amgen position entry and exit signals to maximize returns.
Begin Period Cash Flow | 7.6 B | |
Long Term Debt | 63.2 B | |
Common Stock Shares Outstanding | 538 M | |
Total Stockholder Equity | 6.2 B | |
Total Cashflows From Investing Activities | -26.2 B | |
Tax Provision | 1.2 B | |
Quarterly Earnings Growth Y O Y | -0.463 | |
Property Plant And Equipment Net | 5.9 B | |
Cash And Short Term Investments | 10.9 B | |
Cash | 10.9 B | |
Accounts Payable | 1.6 B | |
Net Debt | 53.7 B | |
50 Day M A | 324.969 | |
Total Current Liabilities | 18.4 B | |
Other Operating Expenses | 20.3 B | |
Non Current Assets Total | 66.8 B | |
Forward Price Earnings | 17.0648 | |
Non Currrent Assets Other | 9.6 B | |
Stock Based Compensation | 473 M |
Additional Information and Resources on Investing in Amgen Stock
When determining whether Amgen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amgen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amgen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amgen Inc Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amgen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amgen. If investors know Amgen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amgen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.46) | Dividend Share 8.76 | Earnings Share 5.81 | Revenue Per Share 57.659 | Quarterly Revenue Growth 0.201 |
The market value of Amgen Inc is measured differently than its book value, which is the value of Amgen that is recorded on the company's balance sheet. Investors also form their own opinion of Amgen's value that differs from its market value or its book value, called intrinsic value, which is Amgen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amgen's market value can be influenced by many factors that don't directly affect Amgen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amgen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amgen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amgen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.